H1 buys General Catalyst-backed Ribbon Healthnews2025-01-09T11:00:50+00:00January 9th, 2025|Endpoints News|
Revance weighs competing buyout offer amid push from original biddernews2025-01-08T20:45:20+00:00January 8th, 2025|Endpoints News|
Transcarent buys health navigation incumbent Accolade for $621Mnews2025-01-08T17:23:49+00:00January 8th, 2025|Endpoints News|
Roche’s Chugai partners with Swiss ADC biotech Ararisnews2025-01-08T13:00:51+00:00January 8th, 2025|Endpoints News|
Novo expands pact with Flagship’s Valo to include obesity, diabetes for $190M near-termnews2025-01-08T11:30:47+00:00January 8th, 2025|Endpoints News|
Sanofi partners with Alloy Therapeutics to make new CNS drugnews2025-01-07T20:33:18+00:00January 7th, 2025|Endpoints News|
BWX Technologies to buy Canadian isotope maker for $525Mnews2025-01-07T16:30:28+00:00January 7th, 2025|Endpoints News|
Pfizer extends AI drug discovery pact with PostEra, adding ADCs to dealnews2025-01-07T16:10:10+00:00January 7th, 2025|Endpoints News|
XyloCor raises $67.5M Series B, updates pivotal gene therapy trial plansnews2025-01-07T12:30:45+00:00January 7th, 2025|Endpoints News|
Exclusive: Avenzo picks up another ADC, this time with multi-partnered DualityBionews2025-01-07T12:00:59+00:00January 7th, 2025|Endpoints News|
